StockClub

KNSA

KNSAKiniksa Pharmaceuticals International, plc$ --
Kiniksa Pharmaceuticals International, plc

Kiniksa Pharmaceuticals International, plc

KNSA

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
214M USD
YoY +55.5%
Operating Income
29M USD
YoY +120.5%
Net Income
23M USD
YoY +164.6%
EPS
0.3$
YoY +150.0%

Revenue

$214.3M
FY2024 Q2$188.5M
$188.5M
Q2
FY2024 Q3$300.7M
$300.7M
Q3
FY2024 Q4$423.2M
$423.2M
Q4
FY2025 Q1$137.8M
$137.8M
Q1
FY2025 Q2$294.6M
$294.6M
Q2
FY2025 Q3$475.4M
$475.4M
Q3
FY2025 Q4$677.6M
$677.6M
Q4
FY2026 Q1$214.3M
$214.3M
Q1
Actual
+$76.5M (+55.5%)

Net Income

$22.6M
FY2024 Q2$-21.6M
$-21.6M
Q2
FY2024 Q3$-34.3M
$-34.3M
Q3
FY2024 Q4$-43.2M
$-43.2M
Q4
FY2025 Q1$8.5M
$8.5M
Q1
FY2025 Q2$26.4M
$26.4M
Q2
FY2025 Q3$44.8M
$44.8M
Q3
FY2025 Q4$59M
$59M
Q4
FY2026 Q1$22.6M
$22.6M
Q1
Actual
+$14.1M (+164.6%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$0
FY2020
$0
FY2021BEAT
Actual:$38.5M
Est:$37.4M
FY2021BEAT
$38.5M
FY2022BEAT
Actual:$220.2M
Est:$203.3M
FY2022BEAT
$220.2M
FY2023MISS
Actual:$270.3M
Est:$338.9M
FY2023MISS
$270.3M
FY2024MISS
Actual:$423.2M
Est:$424.2M
FY2024MISS
$423.2M
FY2025BEAT
Actual:$677.6M
Est:$676.4M
FY2025BEAT
$677.6M

Analyst Estimates